A. Filipov

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

C. Gerloff, D. Blacker, C. Anderson, 2020, The Lancet.

Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke

A. Ebert, K. Szabo, A. Alonso, 2018, Journal of Thrombosis and Thrombolysis.

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

C. Gerloff, T. Neumann-Haefelin, M. Endres, 2020, Neurological Research and Practice.

CO oxidation over CuCr/Al2O3 catalysts in presence of SO2

V. A. Chumachenko, A. Filipov, T. Mulina, 1988 .

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus

A. Ebert, A. Filipov, Vesile Sandikci, 2022, Journal of clinical medicine.